Leadership saw broader commercial potential and decided to spin out the platform team as an independent company, Form Bio.
The launch required simultaneously creating a new company, brand, and category while working with Colossal's corporate marketing group to coordinate and harmonize every detail.
The launch package include visual identity, brand voice, positioning, website, and social channels. I managed internal communications for Form through the transition, and orchestrated the September 2022 public launch—aligning brand reveal, spin out and funding announcement into a single coordinated moment.
We landed feature coverage in Forbes, Business Insider, TechCrunch, PharmaVoice, GenomeWeb, and numerous other industry publications.
Form Bio entered the market with a fully realized brand from day one, and rapidly became a proof point in Colossal's business strategy of spinning off new technologies along its path to de-extinction.
Form's identity system and foundational assets I brought to life endure as part of the company's brand today, and Form Bio has grown into an AI-powered platform relied on by leading cell and gene therapy developers.